Study to Assess Adverse Events and Compare How Oral Ubrogepant and Oral Atogepant Moves Through the Body of Healthy Female Adult Volunteers

Clinical trial NCT05892757 · COMPLETED

Trial details

NCT number: NCT05892757
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2023-07-11
Primary completion: 2024-02-22
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.